1921
Volume 77, Issue 6_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Medicine sellers are widely used for fever and malaria treatment in sub-Saharan Africa, but concerns surround the appropriateness of drugs and information provided. Because there is increasing interest in improving their services, we reviewed the literature on their characteristics and interventions to improve their malaria-related practices. Sixteen interventions were identified, involving a mixture of training/capacity building, demand generation, quality assurance, and creating an enabling environment. Although evidence is insufficient to prove which approaches are superior, tentative conclusions were possible. Interventions increased rates of appropriate treatment, and medicine sellers were willing to participate. Features of successful interventions included a comprehensive situation analysis of the legal and market environment; buy-in from medicine sellers, community members and government; use of a combination of approaches; and maintenance of training and supervision. Interventions must be adapted to include artemisinin-based combination therapies, and their sustainability and potential to operate at a national level should be further explored.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.77.203
2007-12-01
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/77/6_Suppl/0770203.html?itemId=/content/journals/10.4269/ajtmh.2007.77.203&mimeType=html&fmt=ahah

References

  1. Deming MS, Gayibor A, Murphy K, Jones TS, Karsa T, 1989. Home treatment of febrile children with antimalarial drugs in Togo. Bull World Health Organ 67 : 695– 700.
  2. Biritwum RB, Welbeck J, Barnish G, 2000. Incidence and management of malaria in two communities of different socioeconomic level, in Accra, Ghana. Ann Trop Med Parasitol 94 : 771– 778.
  3. Hamel MJ, Odhacha A, Roberts JM, Deming MS, 2001. Malaria control in Bungoma District, Kenya: a survey of home treatment of children with fever, bednet use and attendance at antenatal clinics. Bull World Health Organ 79 : 1014– 1023.
  4. Ruebush TK, Kern MK, Campbell C, Oloo AJ, 1995. Self-treatment of malaria in a rural area of Western Kenya. Bull World Health Organ 73 : 229– 236.
  5. Tsuyuoka R, Wagatsuma Y, Makunike B, 2001. The knowledge and practice on malaria among community members in Zimbabwe. Cent Afr J Med 47 : 14– 17.
  6. Snow RW, Peshu N, Forster D, Mwenesi H, Marsh K, 1992. The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Trans R Soc Trop Med Hyg 86 : 237– 239.
  7. Salako LA, Brieger WR, Afolabi BM, Umeh RE, Agomo PU, Asa S, Adeneye AK, Nwankwo BO, Akinlade CO, 2001. Treatment of childhood fevers and other illnesses in three rural Nigerian communities. J Trop Pediatr 47 : 230– 238.
  8. Ene-Obong HN, Iroegbu CU, Uwaegbute AC, 2000. Perceived causes and management of diarrhoea in young children by market women in Enugu State, Nigeria. J Health Popul Nutr 18 : 97– 102.
  9. Kaseje DC, Spencer HC, Sempebwa EK, 1987. Usage of community-based chloroquine treatment for malaria in Saradidi, Kenya. Ann Trop Med Parasitol 81 (Suppl 1): 111– 115.
  10. Molyneux CS, Mung’Ala Odera V, Harpham T, Snow RW, 1999. Maternal responses to childhood fevers: a comparison of rural and urban residents in coastal Kenya. Trop Med In Health 4 : 836– 845.
  11. Njau JD, Goodman C, Kachur SP, Palmer N, Khatib RA, Abdulla S, Mills A, Bloland P, 2006. Fever treatment and household wealth: the challenge posed for rolling out combination therapy for malaria. Trop Med Int Health 11 : 299– 313.
  12. McCombie SC, 1996. Treatment seeking for malaria: a review of recent research. Soc Sci Med 43 : 933–945.
  13. Krause G, Sauerborn R, 2000. Comprehensive community effectiveness of health care. A study of malaria treatment in children and adults in rural Burkina Faso. Ann Trop Paediatr 20 : 273–282.
  14. Agyepong IA, Manderson L, 1994. Diagnosis and management of fever at household level in the greater Accra region, Ghana. Acta Trop 58 : 317–330.
  15. Geissler PW, Nokes K, Prince RJ, Odhiambo RA, Aagaard-Hansen J, Ouma JH, 2000. Children and medicines: self-treatment of common illnesses among Luo schoolchildren in western Kenya. Soc Sci Med 50 : 1771–1783.
  16. Ezedinachi EN, Ejezie GC, Emeribe AO, 1991. Problems of chloroquine-resistant P. falciparum in Nigeria: one antimalaria drugs’ utilisation in metropolitan Calabar. Cent Afr J Med 37 : 16–20.
  17. Bhattacharya K, Freund P, Amde W, Teshome D, 1997. Community Demand Study for the Essential Services for Health in Ethiopia Project. Washington, DC: BASICS for the United States Agency for International Development.
  18. van der Geest S, 1987. Self-care and the informal sale of drugs in south Cameroon. Soc Sci Med 25 : 293–305.
  19. Adome RO, Whyte SR, Hardon A, 1996. Popular Pills: Community Drug Use in Uganda. Amsterdam: Het Spinhuis.
  20. Goodman CA, 2004. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. PhD Thesis. Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
  21. Williams HA, Jones CO, 2004. A critical review of behavioral issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made? Soc Sci Med 59 : 501–523.
  22. Amin AA, Marsh V, Noor AM, Ochola SA, Snow RW, 2003. The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya. Trop Med Int Health 8 : 1143–1152.
  23. Brieger WR, Sesay HR, Adesina H, Mosanya ME, Ogunlade PB, Ayodele JO, Orisasona SA, 2001. Urban malaria treatment behaviour in the context of low levels of malaria transmission in Lagos, Nigeria. Afr J Med Med Sci 30 (Suppl): 7–15.
  24. Iweze EA, 1987. The patent medicine store: hospital for the urban poor. Makinwa PK, Ozo A, eds. The Urban Poor in Nigeria, 317–322.
  25. Abiola A, AF A, Alhassan M, Famuyide A, Nwaorgu O, Olujohungbe A, Uche F, 1983. A Qualitative Assessment of Medicine Sellers in Igbo-Ora. Ibadan, Nigeria: University of Ibadan. A project submitted to the Department of Preventive and Social Medicine, College of Medicine.
  26. Nshakira N, Kristensen M, Ssali F, Whyte SR, 2002. Appropriate treatment of malaria? Use of antimalarial drugs for children’s fevers in district medical units, drug shops and homes in eastern Uganda. Trop Med Int Health 7 : 309–316.
  27. Marsh VM, Mutemi WM, Muturi J, Haaland A, Watkins WM, Otieno G, Marsh K, 1999. Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health 4 : 383–389.
  28. Okoro BA, Jones IO, 1995. Pattern of drug therapy in home management of diarrhoea in rural communities of Nigeria. J Diarrhoeal Dis Res 13 : 151–154.
  29. Twebaze D, 2001. A Literature Review of Care-seeking Practices for Major Childhood Illnesses in Uganda. Arlington, VA: BASICS II for the United States Agency for International Development.
  30. Basco LK, 2004. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. Am J Trop Med Hyg 70 : 245–250.
  31. Kachur SP, Black C, Abdulla S, Goodman C, 2006. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dares-Salaam. Malar J 5 : 25.
  32. McCombie SC, 2002. Self-treatment for malaria: the evidence and methodological issues. Health Policy Plan 17 : 333–344.
  33. World Health Organization, 2004. Scaling Up Home-Based Management of Malaria. Geneva: Roll Back Malaria Department/UNICEF/UNDP/World Bank/TDR WHO/HTM/MAL/ 2004.1096.
  34. World Health Organization, 2005. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management. Geneva: WHO/HTM/MAL/2005.1101.
  35. Strategies for Enhancing Access to Medicines (SEAM), 2005. Proceedings of Conference on Targeting Improved Access to Essential Medicines. Accra, Ghana. Available from http://www.msh.org/seam/conference2005/
  36. Forum on Engaging the Private Sector in Child Health, 2005. Munyonyo, Uganda.
  37. RBM, 2005. Global Strategic Plan: Roll Back Malaria 2005–2015. Geneva: Roll Back Malaria Partnership, World Health Organization.
  38. WHO and UNICEF, 2003. The Africa Malaria Report. Geneva: WHO/CDS/MAL/2003.1093.
  39. Institute of Medicine, 2004. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington, DC: National Academies Press.
  40. Pagnoni F, Kengeya Kayondo J, Ridley R, Were W, Nafo Traore F, Namboze J, Sirima S, 2005. Artemisinin-based combination treatment in home-based management of malaria. Trop Med Int Health 10 : 621–622.
  41. Goel P, Ross Degnan D, Berman P, Soumerai S, 1996. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med 42 : 1155–1161.
  42. Tawfik Y, Nsungwa-Sabitii J, Greer G, Owor J, Kesande R, Prysor-Jones S, 2006. Negotiating improved case management of childhood illness with formal and informal private practitioners in Uganda. Trop Med Int Health 11 : 967–973.
  43. Brieger WR, Unwin A, Greer G, Meek S, 2004. Interventions to Improve the Role of Informal Private Providers in Malaria Case Management for Children in Africa. BASICS II and the Malaria Consortium. Prepared for The Malaria Case Management Working Group, Roll Back Malaria. Available from http://www.rbm.who.int/partnership/wg/wg_management/docs/medsellersRBMmtgsubcommitteereport.pdf.
  44. Djimdé A, Plowe CV, Diop S, Dicko A, Wellems TE, Doumbo O, 1998. Use of antimalarial drugs in Mali: policy versus reality. Am J Trop Med Hyg 59 : 376–379.
  45. Jimmy EO, Achelonu E, Orji S, 2000. Antimalarials dispensing pattern by patent medicine dealers in rural settlements in Nigeria. Public Health 114 : 282–285.
  46. Ongore D, Nyabola L, 1996. Role of shops and shopkeepers in malaria control. East Afr Med J 73 : 390–394.
  47. Faye O, Faye B, Dieng B, Faye C, O ND, Gaye O, Diallo S, 1996. Informal care of malaria: determinants of demand and supply inventory. A study conducted in Touba City (Senegal). Bull Soc Pathol Exot 89 : 35–40.
  48. Julvez J, 1999. Les ventes de chloroquine dans la rue à Niamey (Niger). Bull Soc Pathol Exot 92 : 31–32.
  49. Nsimba SED, Warsame M, Tomson G, Massele AY, Mbatiya ZA, 1999. A household survey of source, availability and use of antimalarials in a rural area of Tanzania. Drug Infect J 33 : 1025–1032.
  50. Alilio MS, Kamugisha ML, Msuya FK, Massaga JL, Salum FM, Njunwa KJ, 1997. Availability and utilization of antimalarial drugs at community level in same district north eastern Tanzania. Malaria and Infectious Diseases in Africa 6 : 8–12.
  51. Massele AY, Sayi J, Nsimba SE, Ofori Adjei D, Laing RO, 1993. Knowledge and management of malaria in Dar es Salaam, Tanzania. East Afr Med J 70 : 639–642.
  52. Tavrow P, Shabahang J, Makama S, 2003. Vendor-to-vendor education to improve malaria treatment by private drug outlets in Bungoma District, Kenya. Malar J 2 : 1–10.
  53. Goodman C, Kachur SP, Abdulla S, Mwageni E, Nyoni J, Schellenberg JA, Mills A, Bloland P, 2004. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Trop Med Int Health 9 : 655–663.
  54. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A, 2007. Drug shop regulation and malaria treatment in Tanzania–why do shops break the rules, and does it matter? Health Policy Plan 22 : 393–403.
  55. Osamor P, 2001. Knowledge and Selling Practice of Patent Medicine Vendors (PMV) Regarding the Treatment of Malaria in Idikan Community, Ibadan, Oyo State. Dissertation. Department of Health Promotion and Education, College of Medicine, University of Ibadan.
  56. Kachur SP, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland PB, 2006. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Trop Med Int Health 11 : 441– 451.
  57. Battersby A, Goodman C, Abondo C, Mandike R, 2003. Improving the Supply, Distribution and Use of Antimalarial Drugs by the Private Sector in Tanzania. London: Malaria Consortium. Available at http://www.malariaconsortium.org/pages/malariaconsortiumarticles.html.
  58. Patterson AE, Winch PJ, Gilroy KE, Doumbia S, 2006. Local terminology for medicines to treat fever in Bougouni District, Mali: implications for the introduction and evaluation of malaria treatment policies. Trop Med Int Health 11 : 16131624.
  59. Oshiname FO, Brieger WR, 1992. Primary care training for patent medicine vendors in rural Nigeria. Soc Sci Med 35 : 14771484.
  60. Fassin D, 1988. Illicit sale of pharmaceuticals in Africa: sellers and clients in the suburbs of Dakar. Trop Geogr Med 40 : 166–170.
  61. Reynolds Whyte S, Birungi H, 2000. The business of medicines and the politics of knowledge. Whiteford L, Manderson L, eds. Globalization, Health and Identity: The Fallacy of the Level Playing Field. Boulder, CO: Lynne Rienner Publishers.
  62. Cocks M, Dold A, 2000. The role of “ African Chemists” in the health care system of the Eastern Cape province of South Africa. Soc Sci Med 51 : 15051515.
  63. Murray J, Mosazghi A, Kifleysus B, Orobaton N, 1998. Rural Drug Vendors in Eritrea: A Study of Practices and Training Needs. Arlington, VA: Published for USAID by the Basic Support for Institutionalizing Child Survival (BASICS) Project.
  64. Adikwu MU, 1996. Sales practices of patent medicine sellers in Nigeria. Health Policy Plan 11 : 202– 205.
  65. Brieger WR, Osamor PE, Salami KK, Oladepo O, Otusanya SA, 2004. Interactions between patent medicine vendors and customers in urban and rural Nigeria. Health Policy Plan 19 : 177– 182.
  66. Maiga FI, Haddad S, Fournier P, Gauvin L, 2003. Public and private sector responses to essential drugs policies: a multilevel analysis of drug prescription and selling practices in Mali. Soc Sci Med 57 : 937– 948.
  67. Mujinja P, Mpembeni R, Lake S, 2003. Regulating private drug outlets in Dar es Salaam: perceptions of key stakeholders. Soderlund N, Mendoza-Arana P, Goudge J, eds. The New Public/Private Mix in Health: Exploring the Changing Landscape. Geneva: Alliance for Health Policy and Systems Research, 35– 46.
  68. Mosoru Y, Olowookorun O, Spiff I, Otegbayo J, Ejimole W, Fatoki A, Lawani O, 1987. A Survey of Patent Medicine Stores in Tapa and Ayete. Ibadan, Nigeria: University of Ibadan. A project submitted to the Department of Preventive and Social Medicine, College of Medicine.
  69. Akinde J, Effiong C, Obiejesie J, Ogun J, Oloye S, Temiye E, 1982. Survey of Patent Medicine Stores in Igbo-Ora. Ibadan, Nigeria: University of Ibadan. A project submitted to the Department of Preventive and Social Medicine, College of Medicine.
  70. van der Geest S, 1998. The articulation of formal and informal medicine distribution in south Cameroon. van der Geest S, Whyte S, eds. The Context of Medicines in Developing Countries. Dordrecht, The Netherlands: Kluwer Academic Publishers, 131– 148.
  71. Dzator J, Asafu Adjaye J, 2004. A study of malaria care provider choice in Ghana. Health Policy (New York) 69 : 389– 401.
  72. Gilpin U, Adedaji W, Nwokolo E, Akinpelumi A, Anuoyo N, Okolo M, Thomas L, 2006. Artemisinin Combination Therapy (ACTs): Improving Management of Malaria among Patent Medicine Vendors (PMVs) in Lagos, Kano and Abia States. Lagos: Nigeria: Society for Family Health. Technical Report.
  73. Glik DC, Ward WB, Gordon A, Haba F, 1989. Malaria treatment practices among mothers in Guinea. J Health Soc Behav 30 : 421– 435.
  74. Lindblade KA, O’Neill DB, Mathanga DP, Katungu J, Wilson ML, 2000. Treatment for clinical malaria is sought promptly during an epidemic in a highland region of Uganda. Trop Med Int Health 5 : 865– 875.
  75. Molyneux CS, Murira G, Masha J, Snow RW, 2002. Intra-household relations and treatment decision-making for childhood illness: a Kenyan case study. J Biosoc Sci 34 : 109– 131.
  76. Amin AA, Snow RW, 2005. Brands, costs and registration status of antimalarial drugs in the Kenyan retail sector. Malar J 4 : 36.
  77. Indalo A, 1997. Antibiotic sale behaviour in Nairobi: a contributing factor to antimicrobial drug resistance. East Afr Med J 74 : 171– 173.
  78. Amin AA, Hughes DA, Marsh V, Abuya TO, Kokwaro GO, Winstanley PA, Ochola SA, Snow RW, 2004. The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health 9 : 967– 974.
  79. Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson LL, 2003. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J Clin Pharm Ther 28 : 117– 122.
  80. Ogwal Okeng JW, Okello DO, Odyek O, 1998. Quality of oral and parenteral chloroquine in Kampala. East Afr Med J 75 : 692– 694.
  81. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP, 2002. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health 7 : 701– 707.
  82. Shakoor O, Taylor RB, Behrens RH, 1997. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health 2 : 839– 845.
  83. Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA, 2001. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357 : 1933– 1936.
  84. Thompson E, 2006. Analysis of the Antimalarial Drugs Amodiaquine and Artemisinin Derivatives from Rural Tanzania in Order to Determine Drug Quality. MSc Project Report. London: Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine.
  85. Thompson K, 2006. Assessing the Quality of the Antimalarials Quinine and Sulphadoxine/Pyrimethamine in Tanzania. MSc Project Report. London: Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine.
  86. Mburu FM, Spencer HC, Kaseje DC, 1987. Changes in sources of treatment occurring after inception of a community-based malaria control programme in Saradidi, Kenya. Ann Trop Med Parasitol 1 : 105– 110.
  87. Wolf-Gould C, Taylor N, Horwitz S, Barry M, 1991. Misinformation about medications in rural Ghana. Soc Sci Med 33 : 83– 89.
  88. Zurovac D, Rowe AK, 2006. Quality of treatment for febrile illness among children at outpatient facilities in sub-Saharan Africa. Ann Trop Med Parasitol 100 : 283– 296.
  89. Kumaranayake L, Hongoro C, Lake S, Mujinja P, Mpembeni R, 2003. Coping with private health markets— regulatory (in)effectiveness in sub-Saharan Africa. Soderlund N, Mendoza-Arana P, Goudge J, eds. The New Public/Private Mix in Health: Exploring the Changing Landscape. Geneva: Alliance for Health Policy and Systems Research, 47– 59.
  90. Marsh VM, Mutemi WM, Willets A, Bayah K, Were S, Ross A, Marsh K, 2004. Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health 9 : 451– 460.
  91. Brieger W, Ramakrishna J, Adeniyi J, 1986. Self-treatment in rural Nigeria, a community health education diagnosis. Hygiene 5 : 41– 46.
  92. Greer G, Akinpelumi A, Madueke L, Plowman B, Fapohunda B, Tawfik Y, Holmes R, Owor J, Gilpin U, Clarence C, Lennox B, 2004. Improving Management of Childhood Malaria in Nigeria and Uganda by Improving Practices of Patent Medicine Vendors. Arlington, VA.: BASICS II for the United States Agency for International Development.
  93. Goodman CA, Mutemi WM, Baya EK, Willetts A, Marsh V, 2006. The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. Health Policy Plan 21 : 275–288.
  94. Tawfik Y, Northrup R, Prysor-Jones S, 2002. Utilizing the Potential of Formal and Informal Private Practitioners in Child Survival: Situation Analysis and Summary of Promising Interventions: Support for Analysis and Research in Africa (SARA) Project. Washington, DC: Academy for Educational Development. Available from http://pdf.usaid.gov/pdf_docs/PNACP202.pdf
  95. Kumaranayake L, 1997. The role of regulation: influencing private sector activity within health sector reform. J Int Dev 9 : 641–649.
  96. Mujinja P, Lake S, Mpembeni R, 1999. Regulation of the Private Pharmaceutical Sector in Dar es Salaam, Tanzania: A Research Report.
  97. Kaona F, Tuba M, 2003. Improving ability to identify malaria and correctly use chloroquine in children at household level in Nakonde District, northern province of Zambia. Malar J 2 : 43.
  98. Health Communication Project, 2003. Healthy Happy Homes (He Ha Ho) Initiative Ghana, Quarterly Report. Baltimore, MD: HCP, Center for Communications Program, The Johns Hopkins University.
  99. PSI Nigeria/Society for Family Health. Unpublished mimeograph. Pre-Packaged Antimalaria Therapy (PPT) Project (Kid-Care).
  100. The CORE Group, Minnesota International Health Volunteers, 2004. Improving Malaria Case Management in Ugandan Communities: Lessons from the Field. Washington, DC: The Core Group.
  101. Muturi J, 2001. Lessons Learned in Training Retail Sellers on Correct Use of OTC Antimalaria Drugs in Kenya. Kisii, Kenya: Merlin.
  102. PSI Madagascar. Unpublished mimeograph. PaluStop Pre-Packaged Treatment for Simple Malaria in Children under Five in Madagascar.
  103. Brieger W, Salako L, Umeh R, Agomo P, Afolabi B, Adeneye A, 2002. Promoting prepackaged drugs for prompt and appropriate treatment of febrile illnesses in rural Nigerian communities. Int Q Community Health Educ 21 : 19–40.
  104. Ndomondo-Sigonda M, Kowero O, Alphonse E, Hebron Y, Kihinga C, Mbwasi R, Shirima R, Taylor M, Heltzer N, Clark M, 2003. Accredited Drug Dispensing Outlets: A Novel Public-Private Partnership. Dar es Salaam, Tanzania: Tanzania Food and Drugs Authority, Tanzania, Healthscope, and MSH/ SEAM. SEAM (Strategies for Enhancing Access to Medicines) Conference.
  105. Mensah D, 2005. The Licensed Chemical Sellers’ Franchise Model: CAREshops in Ghana. Accra, Ghana: GSMF Enterprises Ltd., and Management Sciences for Health. SEAM (Strategies for Enhancing Access to Medicines) Conference.
  106. BASICS II, 2004. Simulated Visits: Mystery Client Survey. BASICS II Nigeria PMD Evaluation Survey 2004 (Preliminary Results). Arlington, VA: BASICS II for the United States Agency for International Development.
  107. Brieger W, Ogunlade P, 2001. Lessons Learned and Impacts of the CPH Experience in Nigeria. Arlington, VA: BASICS II for the United States Agency for International Development.
  108. PSI, 2006. PSI/Madagascar. Accessed October 31, 2006. Available from http://www.psi.org/where_we_work/madagascar.html
  109. Sigonda-Ndomondo M, 2004. Accredited drug dispensing outlets: improving access to quality drugs and services in rural and peri-urban areas with few or no pharmacies. Second International Conference on Improving Use of Medicines. March 30–April 2. Chiang Mai, Thailand.
  110. Ombogo J, 2005. The Child and Family Wellness Shops Story: Improving Access to Live-Saving Medicines through Micro-Franchising. Accra, Ghana: GSMF Enterprises Ltd., and Management Sciences for Health. SEAM (Strategies for Enhancing Access to Medicines) Conference.
  111. Republic of Uganda Ministry of Health IMCI Unit, SARA Project, August 2002. National Strategy for Utilizing the Potential of Private Practititioners in Child Survival.
  112. Mbwasi R, 2005. Enhancing access to medicines through private and multisector initiatives: The Tanzania experience. Proceedings of the Strategies for Enhancing Access to Medicines (SEAM) Conference on Targeting Improved Access to Essential Medicines. Accra, Ghana.
  113. Sustainable Healthcare Enterprise Foundation. Accessed January 22, 2004. CFWshops Project. Available from http://www.cfwshops.net/project.html.
  114. Mensah D, Bruce E, Eghan K, Staley R, 2003. Essential Medicines Franchise: A Private Sector Approach to Public Health Services. Dar es Salaam, Tanzania: GSMF Enterprises Ltd., and Management Sciences for Health. SEAM (Strategies for Enhancing Access to Medicines) Conference.
  115. Bruce E, 2005. Training of chemical sellers: the CAREshop approach. Proceedings of the Strategies for Enhancing Access to Medicines (SEAM) Conference on Targeting Improved Access to Essential Medicines. Accra, Ghana.
  116. Conteh L, Hanson K, 2003. Methods for studying private sector supply of public health products in developing countries: a conceptual framework and review. Soc Sci Med 57 : 1147–1161.
  117. World Health Organization, 1996. Investing in Health Research and Development: Report of the Ad Hoc Committee on Health Research Relating to Future Intervention Options. Geneva: World Health Organization, TDR/Gen/96.1.
  118. Ross Degnan D, Soumerai SB, Goel PK, Bates J, Makhulo J, Dondi N, Sutoto, Adi D, Ferraz Tabor L, Hogan R, 1996. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies. Health Policy Plan 11 : 308–318.
  119. Tumwikirize WA, Ekwaru PJ, Mohammed K, Ogwal-Okeng JW, Aupont O, 2004. Impact of a face-to-face educational intervention on improving the management of acute respiratory infections in private pharmacies and drug shops in Uganda. East Afr Med J (Suppl): S25–S32.
  120. Ladipo OA, McNamara R, Delano GE, Weiss E, Otolorin EO, 1990. Family planning in traditional markets in Nigeria. Stud Fam Plann 21 : 311–321.
  121. Combary P, Onanga B, Houeto D, Capo-Chichi V, Houendehoto Z, Capo-Chichi S, 2003. Follow-Up of Performance by Pharmacy Agents Trained in Contraceptive Technology between 1998–2001. Benin Technical Report # 35. Chapel Hill, NC: INTRAH, School of Medicine, The University of North Carolina at Chapel Hill.
  122. Anonymous, 1993. Treatment kit nips STDs in the bud. Afr Women Health 1 : 24–26.
  123. Adeokun L, Adejumo S, Adeniji F, Adeniyi C, Akinpelu K, Are-Shodeinde A, Adewunmi O, Ekanem E, Elemide F, Ishola G, 1998. The Ibadan Market Based Distribution Project: Appraisal of the Agent Supervisory Approach. Ibadan, Nigeria: Association for Reproductive and Family Health (ARFH), Monograph Series No. 5.
  124. Garcia PJ, Gotuzzo E, Hughes JP, Holmes KK, 1998. Syndromic management of STDs in pharmacies: evaluation and randomised intervention trial. Sex Transm Infect 74 (Suppl 1): S153–S158.
  125. Garcia P, Hughes J, Carcamo C, Holmes KK, 2003. Training pharmacy workers in recognition, management, and prevention of STDs: district-randomized controlled trial. Bull World Health Organ 81 : 806–814.
  126. Adu-Sarkodie Y, Steiner MJ, Attafuah J, Tweedy K, 2000. Syndromic management of urethral discharge in Ghanaian pharmacies. Sex Transm Infect 76 : 439–442.
  127. Ambegaokar M, Capo-Chichi V, Sebikali B, Echitey N, 2003. Assessing the Performance of Pharmacy Agents in Counselling Family Planning Users and Providing the Pill in Benin: An Evaluation of INTRAH/PRIME and PSI Training Assistance to the Benin Social Marketing Program. Benin Technical Report # 37. North Carolina: INTRAH, School of Medicine, The University of North Carolina at Chapel Hill.
  128. Henry K, 1995. AIDSCAP seeks a private sector solution to the STD self-treatment dilemma. Aidscaptions Mar: 26–29.
  129. Jacobs B, Kambugu F, Whitworth J, Ochwo M, Pool R, Lwanga A, Tifft S, Lule J, Cutler J, 2003. Social marketing of pre-packaged treatment for men with urethral discharge (Clear Seven) in Uganda. Int J STD AIDS 14 : 216–221.
  130. Podhipak A, Varavithya W, Punyaratabandhu P, Vathanophas K, Sangchai R, 1993. Impact of an educational program on the treatment practices of diarrheal diseases among pharmacists and drugsellers. Southeast Asian J Trop Med Public Health 24 : 32–39.
  131. Oshiro Mde L, Castro LL, 2002. Evaluating the potential of an intervention aimed at promoting oral rehydration therapy (ORT) by educating pharmacy employees. Cad Saude Publica 18 : 287–297.
  132. Sia IC, Valerio J, 1997. The effects of an intervention on the drug selling behaviour of sarisari (variety) store keepers in some villages in the Philippines. Chiang Mai, Thailand: Presentation at First ICIUM Meeting.
  133. Larsson M, 2003. Antibiotic use and resistance: assessing and improving provision and utilisation of antibiotics and other drugs in Vietnam. PhD Thesis, Stockholm, Sweden: Karolinska Institute, Division of International Health, Department of Public Health Services.
  134. Chuc NT, Larsson M, Do NT, Diwan VK, Tomson GB, Falkenberg T, 2002. Improving private pharmacy practice: a multi-intervention experiment in Hanoi, Vietnam. J Clin Epidemiol 55 : 1148–1155.
  135. Chalker J, 1995. Effect of a drug supply and cost sharing system on prescribing and utilization: a controlled trial from Nepal. Health Policy Plan 10 : 423–430.
  136. Chalker J, Chuc NT, Falkenberg T, Do NT, Tomson G, 2000. STD management by private pharmacies in Hanoi: practice and knowledge of drug sellers. Sex Transm Infect 76 : 299–302.
  137. Adams EJ, Garcia PJ, Garnett GP, Edmunds WJ, Holmes KK, 2003. The cost-effectiveness of syndromic management in pharmacies in Lima, Peru. Sex Transm Dis 30 : 379–387.
  138. Marsh V, Kachur SP, 2002. Malaria Home Care and Management Malaria Consortium Policy into Strategy and Implementation Series. Available from www.malariaconsortium.org/resources.html.
  139. PSI, 2005. Improved Home Based Management of Malaria Using the Private Sector. Washington, DC: Population Services International, Technical Brief.
  140. Brieger WR, 2002. The Role of Patent Medicine Vendors in the Management of Sick Children in the African Region. Arlington, VA: BASICS II.
  141. United Republic of Tanzania Ministry of Health, July 2005. Levels of Health Care Delivery in Tanzania. Diagnosis and Treatment of Malaria: Orientation Guide for District Trainers. Dar es Salaam, Tanzania: Ministry of Health, 15–19.
  142. D’Alessandro U, Talisuna A, Boelaert M, 2005. Editorial: should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 10 : 1–2.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.77.203
Loading
/content/journals/10.4269/ajtmh.2007.77.203
Loading

Data & Media loading...

  • Received : 26 Dec 2006
  • Accepted : 21 Sep 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error